The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Neomycin and Polymyxin B Sulfates · NEOMYCIN SULFATE 40 mg/mL; POLYMYXIN B SULFATE 200000 [USP'U]/mL · Solution · Irrigation · XGen Pharmaceuticals DJB, Inc.
NDC 39822-1220-01 · 1 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | NEOMYCIN SULFATE 40 mg/mL; POLYMYXIN B SULFATE 200000 [USP'U]/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Neomycin and Polymyxin B Sulfates — NDC 39822-1220-01," retrieved September 3, 2026, https://drugdashboards.com/drug/39822122001.
Free to cite with attribution — see how the data is put together.